71 related articles for article (PubMed ID: 21383269)
1. Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
; Barry MJ; Nicholson WK; Silverstein M; Chelmow D; Coker TR; Davis EM; Donahue KE; Jaén CR; Li L; Ogedegbe G; Rao G; Ruiz JM; Stevermer J; Tsevat J; Underwood SM
JAMA; 2023 Jul; 330(3):253-260. PubMed ID: 37462699
[TBL] [Abstract][Full Text] [Related]
2. Screening and Referral for Childhood Obesity: Adherence to the U.S. Preventive Services Task Force Recommendation.
Imoisili OE; Goodman AB; Dooyema CA; Harrison MR; Belay B; Park S
Am J Prev Med; 2019 Feb; 56(2):179-186. PubMed ID: 30573333
[TBL] [Abstract][Full Text] [Related]
3. An approach to addressing subpopulation considerations in systematic reviews: the experience of reviewers supporting the U.S. Preventive Services Task Force.
Whitlock EP; Eder M; Thompson JH; Jonas DE; Evans CV; Guirguis-Blake JM; Lin JS
Syst Rev; 2017 Mar; 6(1):41. PubMed ID: 28253915
[TBL] [Abstract][Full Text] [Related]
4. Putting Evidence Into Practice: An Update on the US Preventive Services Task Force Methods for Developing Recommendations for Preventive Services.
Barry MJ; Wolff TA; Pbert L; Davidson KW; Fan TM; Krist AH; Lin JS; Mabry-Hernandez IR; Mangione CM; Mills J; Owens DK; Nicholson WK
Ann Fam Med; 2023; 21(2):165-171. PubMed ID: 36973047
[TBL] [Abstract][Full Text] [Related]
5. USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents.
McGowan MP; Cuchel M; Lee PC
JAMA; 2023 Nov; 330(20):2023-2024. PubMed ID: 38015225
[No Abstract] [Full Text] [Related]
6. USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents.
Wilemon K; Knowles JW; Baum SJ
JAMA; 2023 Nov; 330(20):2024. PubMed ID: 38015224
[No Abstract] [Full Text] [Related]
7. USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents.
Santos RD; Libby P; Watts GF
JAMA; 2023 Nov; 330(20):2022-2023. PubMed ID: 38015223
[No Abstract] [Full Text] [Related]
8. Recommendations on routine screening pelvic examination: Canadian Task Force on Preventive Health Care adoption of the American College of Physicians guideline.
Tonelli M; Connor Gorber S; Moore A; Thombs BD;
Can Fam Physician; 2016 Mar; 62(3):211-4. PubMed ID: 26975912
[TBL] [Abstract][Full Text] [Related]
9. Update on age-appropriate preventive measures and screening for Canadian primary care providers.
Shimizu T; Bouchard M; Mavriplis C
Can Fam Physician; 2016 Feb; 62(2):131-8. PubMed ID: 26884526
[TBL] [Abstract][Full Text] [Related]
10. USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents-Reply.
Barry MJ; Li L
JAMA; 2023 Nov; 330(20):2024-2025. PubMed ID: 38015221
[No Abstract] [Full Text] [Related]
11. NLA/ASPC response to the USPSTF recommendation statement on screening lipid panel in children and adolescents.
Goldberg AC; Soffer D; Ballantyne C; Gulati M; Shapiro M
J Clin Lipidol; 2023; 17(5):559-560. PubMed ID: 37806802
[No Abstract] [Full Text] [Related]
12. Screening for and management of obesity in adults: u.s. Preventive services task force recommendation statement: a policy review.
Yao A
Ann Med Surg (Lond); 2013; 2(1):18-21. PubMed ID: 25973185
[No Abstract] [Full Text] [Related]
13. Overcoming the real and imagined barriers to cholesterol screening in pediatrics.
Schubert TJ; Gidding SS; Jones LK
J Clin Lipidol; 2024; 18(3):e297-e307. PubMed ID: 38485620
[TBL] [Abstract][Full Text] [Related]
14. Lipid Screening and Treatment Practices Conflict With Conflicting Recommendations: Where Do We Go From Here?
Barlow SE; Turer CB
J Pediatr; 2017 Jun; 185():16-18. PubMed ID: 28284479
[No Abstract] [Full Text] [Related]
15. The Subjective Interpretation of the Medical Evidence.
Bauchner H; Ioannidis JPA
JAMA Health Forum; 2024 Mar; 5(3):e240213. PubMed ID: 38551587
[TBL] [Abstract][Full Text] [Related]
16. Systematic Review Evidence Methodology: Providing Quality Family Planning Services.
Tregear SJ; Gavin LE; Williams JR
Am J Prev Med; 2015 Aug; 49(2 Suppl 1):S23-30. PubMed ID: 26190844
[TBL] [Abstract][Full Text] [Related]
17. The anatomy of a US Preventive Services Task Force Recommendation: lipid screening for children and adolescents.
Grossman DC; Moyer VA; Melnyk BM; Chou R; DeWitt TG;
Arch Pediatr Adolesc Med; 2011 Mar; 165(3):205-10. PubMed ID: 21383269
[TBL] [Abstract][Full Text] [Related]
18. Vision screening for children 1 to 5 years of age: US Preventive Services Task Force Recommendation statement.
US Preventive Services Task Force
Pediatrics; 2011 Feb; 127(2):340-6. PubMed ID: 21282267
[TBL] [Abstract][Full Text] [Related]
19. Screening and interventions for overweight in children and adolescents: recommendation statement.
US Preventive Services Task Force
Pediatrics; 2005 Jul; 116(1):205-9. PubMed ID: 15995054
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
